Want to join the conversation?
In March, $REGN reported positive data from the Phase III Odyssey Escape study in patients with heterozygous familial hypercholesterolemia. Earlier this week, for Fasinumab, its NGF antibody, $REGN announced positive data from its Phase II/III study in osteoarthritis.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?